Introduction: Early identification of Tuberculosis (TB) treatment failure using cost effective means is urgently needed in developing nations. The study set out to describe affordable predictors of TB treatment failure in an African setting.
Introduction
The control of tuberculosis (TB) remains a challenge globally, 1, 2 more so in sub-Saharan Africa 2 and in high burden countries like Uganda where treatment target goals have not yet been met. 2 For TB control, the highest priority is to detect at least 70% of the sputum smear positive cases and to cure at least 85% of the sputum smear positive cases. If these targets are achieved, there is a decrease in prevalence, incidence, transmission and drug resistance to TB. 3 Treatment failure of TB, which is defined as a patient who is sputum smear or sputum culture positive at 5 months or later after the initiation of anti TB treatment, 3 is one of the threats to the control of TB. This is because of its association with Multi Drug Resistant TB (MDR TB) 4 and also because affected patients continue to spread TB. Patients with treatment failure have a higher morbidity and mortality compared to those who achieve cure. 5 The World Health Organization (WHO) recommends diagnosis of TB treatment failure in resource limited settings by sputum smear microscopy at 5 months or later during treatment. 3 However, identification of those at risk of treatment failure is important before the 5 months in reducing TB spread, morbidity and mortality in affected individuals and may help in contributing to the achievement of the treatment targets. The ideal tool for this is frequent laboratory monitoring using sputum microscopy or culture. However, culture is not feasible in many settings with limited laboratory" resources like most of Uganda.
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Given these constraints there is need to obtain more easily measurable surrogate markers that may serve as predictors of TB treatment failure. Those patients identified to have the predictors of TB treatment failure may be prioritized for the use of limited laboratory resources. Studies done in other settings show that these predictors include social, radiological, laboratory and treatment related factors. 4, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] No study had been done in our setting to identify these predictors and we did a case control study to identify them.
Methods

Ethical considerations
The study was approved by the Makerere University Faculty of Medicine Research and Ethics Committee. All participants gave written informed consent to participate. Assent was obtained from those who were under 18 years of age, in addition to the consent of their parents or guardians.
Study site
The study was conducted between June and December 2007 at Uganda's main national referral hospital of Mulago, in Kampala.
Study design and population
An unmatched retrospective case control study of the predictors of treatment failure among patients with sputum smear positive pulmonary TB was conducted.
Eligible patients thirteen years and above, with sputum smear positive TB at initiation of treatment and a positive sputum smear at 5 months or later after start of TB treatment were recruited. Controls were patients who were thirteen years of age and above, with sputum smear positive TB at initiation of treatment and had a negative sputum smear at 5 and 8 months after start of anti TB treatment.
Poor adherence was used to calculate the sample size since it is one of the most important predictors of treatment failure from previous studies. We used a level of poor adherence among treatment failure patients of 40% and 15% among patients who were cured. 21 Using the formula for comparison of proportions a minimum sample size of 120 subjects (40 cases, 80 controls) would be needed to achieve 80% power with a level of significance of 0.05 20 To increase the power of the study 50 cases and 100 controls were recruited Study procedure Data abstraction was done from medical records, patients' charts, and clinic cards in addition to interviewing patients. Those with incomplete records were excluded. A radiologist reviewed archived chest radiographs, which had been done at the time of diagnosis of TB. All data were recorded on a structured questionnaire. Information collected included age, gender, marital status, highest education level attained, approximate distance to the TB clinic, alcohol or substance abuse, fever persisting after 2 weeks of TB treatment, weight loss despite treatment or no weight gain, sputum smear microscopy results at baseline, 2 months and 5 months or later during treatment, drugs doses given and the presence of other medical conditions including HIV and Diabetes Mellitus (DM). All patients in this clinic were on the same treatment regimen, which is 2 months of rifampicin, isoniazid, ethambutol and pyrazinamide followed by 6 months of ethambutol and isoniazid.
Predictors of treatment failure were defined as factors which are associated with treatment failure and may be used to identify those at risk of treatment failure. These include socio-demographic, clinical, laboratory, radiological, and treatment associated factors. Alcohol abuse was defined as a CAGE score of 2 and above
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. Any weight gain or loss was calculated by subtracting the patients' weight at the start of TB treatment, from the weight at the time the patient was diagnosed with treatment failure or declared cured.
Results of the HIV test were obtained from the patients' medical records. All patients in the TB clinic are routinely counseled and tested for HIV. Random blood sugar was tested using a Glucometer (One Touch Ultra AW 060-368-13D Rev.03/2004, lifescan Inc. Milpitas, California Unites States of America). Diabetes Mellitus (DM) was defined as a random blood sugar of 200mg/dl and above in the presence of classic symptoms of hyperglycaemia. 23 Persistent fever was defined as fever lasting 2 or more weeks after initiation of anti TB treatment while a high bacillary load was defined as any sputum smear graded as having more than 10 acid alcohol fast bacilli per high power oil immersion field or grade +++ in the laboratory.
Adherence was assessed by taking a meticulous history to find out if patients missed any treatment and by asking them to estimate the duration of any treatment interruption. To minimize recall bias, adherence to treatment was crosschecked using the treatment card, which has space where patients or their relatives check after taking medication. Poor adherence was also assumed if the patients did not return for a scheduled appointment within a week of expected review on two or more occasions. Extensive radiological involvement was defined as lesion(s) involving an area of more than the equivalent of one lung with or without cavities.
Data analysis
The data obtained was entered into Epi info 3.2.2 version, then exported to SPSS version 12.0 software for analysis.
Univariate analysis was performed to describe the baseline characteristics of the participants while bivariate analysis was performed to assess for possible associations between the individual predictor variables and the outcome predictor variable, which was TB treatment failure. Binary logistic regression using the backward elimination method was performed to determine the predictor variables while adjusting for confounding. The association between TB treatment failure and independent variables was assessed using odds ratios, 95% confidence intervals and p values. A p value of 0.05 or less was considered significant. The Chi-square tests were computed and the Fisher's exact test was used for cell frequencies less than five.
Results
Of Table 1 . 
Discussion
This study examined socio-demographic, clinical, radiological, laboratory and treatment related factors associated with treatment failure in the TB clinic in Mulago hospital, Kampala. We found that a positive sputum smear at 2 months of anti TB treatment and poor adherence to anti TB treatment were predictors of treatment failure. None of the sociodemographic factors was associated with TB treatment failure in our study. Living further from the TB clinic had earlier been found to be associated with treatment failure by Shargie et al in 2007 in Ethiopia (HR 2.97, p<0.001) 24 . This may be due to failure to return for drug refills because of the longer distance, leading to poor adherence. In our setting the effects of this factor could have been masked by presence of various TB clinics within the city. Our study did not find alcohol abuse, lower level of education and male gender to be risk factors for TB treatment failure contrary to studies elsewhere 7, 8 . There may be other socio-cultural characteristics among our population that blunted any differences. , weight loss 10, 11 and HIV 12 seropositivity were not significant in our study.
A positive sputum smear at 2 months of TB treatment was found to be the strongest predictor of treatment failure in our study. This is in agreement with Chavez et al's finding in Peru (OR 1.7, p=0.008) 6 . This is an important observation since sputum microscopy is a low cost investigation and that can be used by TB programs to identify those at risk for early intervention. The first 2 months of TB treatment is when there is rapid killing of actively dividing bacilli and the semi-dormant bacilli. The majority of sputum smear positive patients turn negative within this period 3 . It is possible that a positive sputum smear at 2 months is due to primary drug resistance or alternatively, selection of mutant strains leading to MDR TB and treatment failure especially in the context of poor adherence 25 . This emphasizes the recommendation by TB programs to prolong the intensive phase if the sputum smear is positive at 2 months 3 . A high bacillary load at baseline was not associated with treatment failure in this study contrary to findings by Singla et al (p<0.001). 13 These differences could be accounted for by the higher rate of default on treatment among those who had a higher bacillary load and the intermittent regimen used in Singla's study. 13 It is noteworthy that Keane et al who used a treatment regimen similar to ours did not find high bacillary load at start of treatment a predictor of treatment failure. 11 Presence of cavities on the chest radiograph and extensive radiological involvement were not found to be significantly associated with treatment failure at multivariate analysis contrary to what was demonstrated by Qingsong et al (OR 1.5, p=<0.001) 14 This was probably due to inadequate sample size. Poor adherence to treatment was also a predictor of treatment failure in our study. This is in agreement with findings of Morsy et al 
Conclusion
Positive sputum smear at 2 months of TB treatment and poor adherence to anti TB treatment were found to be predictors of TB treatment failure in Mulago Hospital. These factors may be used in resource limited settings for early recognition of those at risk and early intervention.
Recommendations
The National TB programs should emphasize the recommendation of sputum microscopy at 2 months of treatment to detect those at risk so that they can be followed up closely. Patients with poor adherence to treatment should be closely followed up to prevent treatment failure. Studies need to be done to find out the effect of prolonging the intensive phase of treatment in those with positive sputum smears at 2 months.
Limitations of the study
Culture and sensitivity of TB was not done for controls so it was difficult to tell if drug resistance was a predictor of treatment failure. Some patients were excluded because they were missing important data in their records. This may have introduced bias if having missing records is related to certain risk factors. The definition of treatment failure used was the one recommended by WHO for resource limited settings and therefore sputum culture was not used in the definition, which could have led to misclassification of cases and controls. Serum drug levels to quantify adherence were not feasible in our study. The sample size was inadequate as shown by the wide confidence intervals and therefore some predictors with lower odds ratios could have been missed.
